Tao Y, Tian C, Qi S, Jia Z, Xu Z, Meng J
Nat Cancer. 2025; .
PMID: 40075237
DOI: 10.1038/s43018-025-00930-5.
Tang Y, Tang T, Li Y, Wu J, Liu X, Xiang D
Int J Nanomedicine. 2025; 20:2743-2759.
PMID: 40066322
PMC: 11892501.
DOI: 10.2147/IJN.S508696.
Guc E, Treveil A, Leach E, Broomfield A, Camera A, Clubley J
Nat Commun. 2025; 16(1):2374.
PMID: 40064880
PMC: 11893752.
DOI: 10.1038/s41467-025-57470-w.
Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y
Signal Transduct Target Ther. 2025; 10(1):93.
PMID: 40055311
PMC: 11889221.
DOI: 10.1038/s41392-025-02124-y.
Zhang Y, Liu Y, Luo S, Liang H, Guo C, Du Y
Clin Transl Med. 2025; 15(3):e70252.
PMID: 40000418
PMC: 11859120.
DOI: 10.1002/ctm2.70252.
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes.
Shi T, Zhang H, Chen Y
Cell Biosci. 2025; 15(1):27.
PMID: 39987091
PMC: 11846233.
DOI: 10.1186/s13578-025-01368-z.
Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment.
In H, Park M, Lee H, Han K
Antibodies (Basel). 2025; 14(1).
PMID: 39982231
PMC: 11843982.
DOI: 10.3390/antib14010016.
Enhancing antitumour immunity with photodynamic therapy.
Selbo P, Korbelik M
Photochem Photobiol Sci. 2025; 24(2):227-234.
PMID: 39971873
DOI: 10.1007/s43630-025-00690-2.
Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma.
Kong D, Zhang Y, Jiang L, Long N, Wang C, Qiu M
Sci Rep. 2025; 15(1):3995.
PMID: 39893200
PMC: 11787346.
DOI: 10.1038/s41598-025-88071-8.
The micro(nano)plastics perspective: exploring cancer development and therapy.
Deng X, Gui Y, Zhao L
Mol Cancer. 2025; 24(1):30.
PMID: 39856719
PMC: 11761189.
DOI: 10.1186/s12943-025-02230-z.
The Microenvironment in DCIS and Its Role in Disease Progression.
Roozitalab M, Prekete N, Allen M, Grose R, Jones J
Adv Exp Med Biol. 2025; 1464():211-235.
PMID: 39821028
DOI: 10.1007/978-3-031-70875-6_12.
Bioinformatics-based analysis of the role of immune-related genes in acute rejection after kidney transplantation and renal cancer development.
Huang S, Yin H
Medicine (Baltimore). 2025; 103(47):e40270.
PMID: 39809189
PMC: 11596506.
DOI: 10.1097/MD.0000000000040270.
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E
J Hematol Oncol. 2025; 18(1):6.
PMID: 39806516
PMC: 11733683.
DOI: 10.1186/s13045-024-01634-6.
Myeloid cells meet CD8 T cell exhaustion in cancer: What, why and how.
Zhai Y, Liang X, Deng M
Chin J Cancer Res. 2025; 36(6):616-651.
PMID: 39802897
PMC: 11724180.
DOI: 10.21147/j.issn.1000-9604.2024.06.04.
Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy.
Kang S, Mansurov A, Kurtanich T, Chun H, Slezak A, Volpatti L
J Immunother Cancer. 2025; 12(12).
PMID: 39794939
PMC: 11667343.
DOI: 10.1136/jitc-2024-009541.
Reinventing type 2 immunity in cancer.
Wagner M, Nishikawa H, Koyasu S
Nature. 2025; 637(8045):296-303.
PMID: 39780006
DOI: 10.1038/s41586-024-08194-2.
Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma.
Oura K, Morishita A, Tadokoro T, Fujita K, Tani J, Kobara H
Int J Mol Sci. 2025; 25(24.
PMID: 39769351
PMC: 11679663.
DOI: 10.3390/ijms252413590.
Artificial intelligence model predicts M2 macrophage levels and HCC prognosis with only globally labeled pathological images.
Tian H, Tian Y, Li D, Zhao M, Luo Q, Kong L
Front Oncol. 2025; 14:1474155.
PMID: 39759153
PMC: 11695232.
DOI: 10.3389/fonc.2024.1474155.
Breast pericytes: a newly identified driver of tumor cell proliferation.
Del Toro K, Licon-Munoz Y, Crabtree W, Oper T, Robbins C, Hines W
Front Oncol. 2025; 14():1455484.
PMID: 39741968
PMC: 11685225.
DOI: 10.3389/fonc.2024.1455484.
Mechanical Force-Induced cGAS Activation in Carcinoma Cells Facilitates Splenocytes into Liver to Drive Metastasis.
Zhang X, Huang N, Mu Y, Chen H, Zhu M, Zhang S
Adv Sci (Weinh). 2024; 12(8):e2401127.
PMID: 39737867
PMC: 11848607.
DOI: 10.1002/advs.202401127.